{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"86.3","upperLimit":"98.5","value":"95.4"},{"groupId":"OG001","lowerLimit":"65.8","upperLimit":"91.9","value":"82.9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"35"}],"units":"Participants"}],"description":"EFS - time from study entry until failure to achieve complete remission during consolidation, relapse, or death. For further clarification see definitions provided in the protocol.","dispersionType":"95% Confidence Interval","groups":[{"description":"WBC\\<10,000/MicroLiter","id":"OG000","title":"Standard Risk"},{"description":"WBC\\>=10,000/MicroLiter","id":"OG001","title":"High Risk"}],"paramType":"NUMBER","populationDescription":"Ineligible and inevaluable patients are excluded from analyses of EFS.","reportingStatus":"POSTED","timeFrame":"At 3 years from study entry","title":"Event-free Survival (EFS)","type":"PRIMARY","unitOfMeasure":"Percentage of participants"}